Figure 3
From: Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus
Effects of Lenalidomide on anti-dsDNA antibody and complement levels. Comparison of anti-dsDNA antibody titres (A) and complement levels (B) at baseline and after completing the course of treatment.
